Redmile Group, LLC Avita Medical, Inc. Transaction History

Redmile Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.96 - $12.15 $4.68 Million - $8.17 Million	-672,411 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$11.72 - $19.66 $7.9 Million - $13.2 Million	-673,806 Reduced 50.05%	672,411 $8.06 Million
Q3 2021 Nov 15, 2021	SELL	$16.73 - $20.9 $1.09 Million - $1.36 Million	-64,900 Reduced 4.6%	1,346,217 $23.9 Million
Q2 2021 Aug 16, 2021	SELL	$17.23 - $22.02 $4.43 Million - $5.66 Million	-257,210 Reduced 15.42%	1,411,117 $29 Million
Q1 2021 May 17, 2021	SELL	$18.38 - $28.41 $717,904 - $1.11 Million	-39,059 Reduced 2.29%	1,668,327 $33.1 Million
Q4 2020 Feb 16, 2021	SELL	$17.55 - $27.2 $1.27 Million - $1.96 Million	-72,200 Reduced 4.06%	1,707,386 $31.7 Million
Q3 2020 Nov 16, 2020	BUY	$20.83 - $30.0 $37.1 Million - $53.4 Million	1,779,586 New	1,779,586 $44.8 Million

5.96M

35.5K

38K

Ticker RCEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,030,900
Market Cap $320M
Description
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.